Fresenius Medical Care AG
FME: XETR (DEU)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| T&^ | LOCK|fC<< | LOCK|?KQ@z#^ |
Fresenius Medical Care Earnings: 2026 Outlook Roughly Intact, but Initial 2027 View Looks Murky
On Nov. 3, Fresenius Medical Care reported third-quarter results that included flat organic revenue, a 6% decline in adjusted operating income, and flat adjusted EPS, including recent share repurchases. Management also narrowed its 2026 outlook and gave initial commentary for 2027.
